To review and analyze the repurposing of phenytoin as a treatment for bipolar disorders. Phenytoin is an 80-years-old drug and its putative clinical value is neglected for psychiatric disorders. Only few studies have been published in this field, and most studies are pilot trials.
No takes yet. Share an insight, caveat, or question.
Hesselink et al. (2019) studied this question.
Synapse has enriched 4 related papers. Consider them for comparative context: